Celonova Biosciences Inc.

NEWNAN, Georgia, December 1 - CeloNova BioSciences, Inc., a provider of specialty surface treatments for medical devices and of specialty implants, today announced that President and Chief Executive Officer, Thomas A.

NEWNAN, Georgia, December 1 - CeloNova BioSciences, Inc., a provider of specialty surface treatments for medical devices and of specialty implants, today announced that Barry Katzen, MD, FACR, FACC, FSCAI, founder and medical director of Baptist Cardiac & Vascular Institute in Miami, Florida, will discuss the CATANIA(TM) Stent System with NanoThin Polyzene(R)-F at the Innovations in Cardiovascular Interventions Conference to be held at the Hotel David InterContinental in Tel Aviv, Israel, which will include new information about the stent's coating, Polyzene(R)-F, and clinical outcomes in coronary, below-the-knee, and neurovascular applications.